JOSE PABLO
MIRAMONTES GONZALEZ
PROFESOR CONTRATADO DOCTOR
Hospital Universitario Virgen Macarena
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (10)
2024
2020
-
In response to the paper ‘High-protein diet: A barrier to the nephroprotective effects of sodium-glucose co-transporter-2 inhibitors?’
Diabetes, Obesity and Metabolism
-
Inflammation, malnutrition, and SARS-CoV-2 infection: a disastrous combination
Revista Clinica Espanola, Vol. 220, Núm. 8, pp. 511-517
2019
-
Could renin-angiotensin-aldosterone system activation explain the amputations associated with canagliflozin? The nitric oxide hypothesis
Diabetes Research and Clinical Practice, Vol. 148, pp. 10-13
-
Diuretic treatment of the patient with diabetes and heart failure. Role of SGLT2 inhibitors and similarities with carbonic anhydrase inhibitors
Revista Clinica Espanola, Vol. 219, Núm. 4, pp. 208-217
-
VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia
Atherosclerosis, Vol. 285, pp. 17-22
2018
-
Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease
American Journal of Physiology - Renal Physiology, Vol. 315, Núm. 5, pp. F1406-F1415
-
Reply to ‘Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes’ by Yoshimoto et al.
Journal of Investigative Medicine
-
The mechanism of action of sodium–glucose co-transporter 2 inhibitors is similar to carbonic anhydrase inhibitors
European Journal of Heart Failure
-
Update concept of the dual blocking of the renin-angiotensin-aldosteron system. A new therapeutic option?
Medicina Clinica, Vol. 150, Núm. 1, pp. 33-38